Intrahepatic Bile Duct (SBDIH)
- For resection specimens with carcinomas and combined hepatocellular-cholangiocarcinomas of the intrahepatic bile ducts.
Specimen and Surgical Procedure
Specimen, procedure....................................................................
Tumor
Tumor size...................................................................................
Tumor focality..............................................................................
Histologic type..............................................................................
Histologic grade............................................................................
Tumor growth pattern...................................................................
Classify as one of the following
- Mass-forming
- Periductal infiltrating (T4)
- Mixed mass-forming and periductal infiltrating (T4)
- Cannot be determined
Microscopic tumor extension..........................................................
Lymph-vascular invasion (either type increases solitary tumors to T2a)
Venous (major vessel)*............................................................... present/absent
* invasion of R or L portal vein, 1 or more hepatic veins
Small vessel............................................................................... present/absent
Perineural invasion...................................................................... present/absent
Final margins
Nearest margin............................................................................
Distance from specified margin to tumor.........................................
Bile duct margin....................................................................... positive/negative
Carcinoma in situ/high grade dysplasia at margin.................... present/absent
Hepatic parenchymal margin...................................................... positive/negative
Other margin(s) (if applicable; please specify).............................. positive/negative
Lymph Nodes
Regional lymph nodes (involved/examined).................................. __/__
Other Findings
Findings in non-neoplastic liver...................................................
Pathologic stage...................................................................... pT__N__M__